BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol 2015; 21(6): 1956-1971 [PMID: 25684965 DOI: 10.3748/wjg.v21.i6.1956]
URL: https://www.wjgnet.com/1007-9327/full/v21/i6/1956.htm
(427) (378) (0) (0) (21930) (197)
Number Citing Articles
1
Franziska Mathies, Niklas Steffens, Doerte Kleinschmidt, Friederike Stuhlmann, Francis J Huber, Urmi Roy, Thomas Meyer, Marc Luetgehetmann, Mareike von Petersdorff, Oliver Seiz, Johannes Herkel, Christoph Schramm, Richard A Flavell, Nicola Gagliani, Christian Krebs, Ulf Panzer, Zeinab Abdullah, Till Strowig, Tanja Bedke, Samuel Huber. Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells. The Journal of Immunology 2018; 201(12) doi: 10.4049/jimmunol.1800711
2
Christopher Chang, Atsushi Tanaka, Christopher Bowlus, M. Eric Gershwin. The use of biologics in the treatment of autoimmune liver disease. Expert Opinion on Investigational Drugs 2020; 29(4) doi: 10.1080/13543784.2020.1733527
3
Christian Schineis. Chirurgie des unteren Gastrointestinaltrakts und Allgemeine Chirurgie. Springer Reference Medizin 2024;  doi: 10.1007/978-3-662-63356-4_72
4
Shintaro Akiyama, Soma Fukuda, Joshua M Steinberg, Hideo Suzuki, Kiichiro Tsuchiya. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases. World Journal of Gastroenterology 2022; 28(25): 2843-2853 doi: 10.3748/wjg.v28.i25.2843
5
Kwang Woo Kim, Hyoun Woo Kang. Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease. Intestinal Research 2023; 21(4) doi: 10.5217/ir.2023.00133
6
Alicia R. Andrews, Juan Putra. Special Considerations in Pediatric Inflammatory Bowel Disease Pathology. Diagnostics 2025; 15(7) doi: 10.3390/diagnostics15070831
7
Haruka Okada, Shinya Sugimoto, Atsuto Kayashima, Yohei Mikami, Takanori Kanai, Nobuhiro Nakamoto, Yusuke Yoshimatsu, Hiroki Kiyohara, Yukie Nakadai, Ryosuke Kasuga, Nobuhito Taniki, Keisuke Ojiro, Shingo Usui, Shogo Sunaga, Ichiro Mizushima, Yuta Kaieda, Shohei Suzuki, Takaya Tabuchi, Makoto Ueno. Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease. Journal of Gastroenterology 2026;  doi: 10.1007/s00535-026-02388-3
8
Elisa Catanzaro, Enrico Gringeri, Nora Cazzagon, Annarosa Floreani, Umberto Cillo, Patrizia Burra, Martina Gambato. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. Journal of Personalized Medicine 2024; 14(3) doi: 10.3390/jpm14030222
9
David Huynh, Denis Rubtsov, Myat Myat Khaing. Efficacy of Biologics in the Treatment of Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Cureus 2024;  doi: 10.7759/cureus.56182
10
Gabriele Bislenghi, Caroline Nordenvall, Anthony de Buck van Overstraeten, Peter Kienle, Alaa El‐Hussuna. Pouch Surgery for Ulcerative Colitis: Navigating Complexity in the Modern Era. JCC Plus 2026; 1(3) doi: 10.1002/jcc5.70031
11
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. American Journal of Gastroenterology 2020; 115(6) doi: 10.14309/ajg.0000000000000604
12
Christopher Bowlus, David N. Assis, David Goldberg. Zakim and Boyer's Hepatology. 2018;  doi: 10.1016/B978-0-323-37591-7.00043-4
13
Kate D. Williamson, Roger W. Chapman. Primary sclerosing cholangitis: a clinical update. British Medical Bulletin 2015; 114(1) doi: 10.1093/bmb/ldv019
14
Christian Schineis. Viszeral- und Allgemeinchirurgie. Springer Reference Medizin 2022;  doi: 10.1007/978-3-662-61724-3_72-1
15
Kimberly Ortiz, Zeliha Cetin, Yiyue Sun, Zhiping Hu, Takeshi Kurihara, Edgar N. Tafaleng, Rodrigo M. Florentino, Alina Ostrowska, Alejandro Soto-Gutierrez, Lanuza A.P. Faccioli. Human Hepatocellular response in Cholestatic Liver Diseases. Organogenesis 2023; 19(1) doi: 10.1080/15476278.2023.2247576
16
Amera Elzubeir, Juliet High, Matthew Hammond, Lee Shepstone, Martin Pond, Martine Walmsley, Palak Trivedi, Emma Culver, Guruprasad Aithal, Jessica Dyson, Douglas Thorburn, Leo Alexandre, Simon Rushbrook. Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study. BMJ Open Gastroenterology 2025; 12(1) doi: 10.1136/bmjgast-2024-001596
17
Fangming Wang, Junhui Xiao. The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-83085-0
18
Olga V. Usoltseva, Andrey N. Surkov, Alexander S. Potapov, Goar B. Movsisyan, Vladislav V. Chernikov. Association of autoimmune hepatobiliary pathology with inflammatory bowel diseases in children. Russian Pediatric Journal 2022; 25(2) doi: 10.46563/1560-9561-2022-25-2-106-115
19
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
20
Eike Matthias Wacker, Florian Uellendahl-Werth, Saptarshi Bej, Olaf Wolkenhauer, Mette Vesterhus, Wolfgang Lieb, Andre Franke, Tom Hemming Karlsen, Trine Folseraas, David Ellinghaus. Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis. JHEP Reports 2024; 6(2) doi: 10.1016/j.jhepr.2023.100988
21
Mahmoud Mahfouz, Paul Martin, Andres F. Carrion. Hepatic Complications of Inflammatory Bowel Disease. Clinics in Liver Disease 2019; 23(2) doi: 10.1016/j.cld.2018.12.003
22
Ming-Hsi Wang, Jessica J. Friton, Nancy Rebert, Kelly Monroe, Billy D. Nix, Claudio Fiocchi, Laura E. Raffals, Jonathan A. Leighton, Shabana F. Pasha, Michael F. Picco, Rodney D. Newberry, Jean-Paul Achkar, William A. Faubion. Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis. Clinical and Translational Gastroenterology 2023; 14(9) doi: 10.14309/ctg.0000000000000615
23
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, Martina Gambato. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. Cancers 2023; 15(20) doi: 10.3390/cancers15204947
24
In Sub Han, Dong Hoon Baek, Seung Min Hong, Bong Eun Lee, Moon Won Lee, Gwang Ha Kim, Geun Am Song. Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04464-z
25
Ruben J. Colman, Jasbir Dhaliwal, Michael J. Rosen. Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.634739
26
Bettina M Buchholz, Panagis M Lykoudis, Reena Ravikumar, Joerg M Pollok, Giuseppe K Fusai. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients. World Journal of Gastroenterology 2018; 24(28): 3171-3180 doi: 10.3748/wjg.v24.i28.3171
27
Brian M Fung, Keith D Lindor, James H Tabibian. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World Journal of Gastroenterology 2019; 25(6): 659-671 doi: 10.3748/wjg.v25.i6.659
28
Mohammad Egbaria, Amir Bieber, Abed Mahamid, Rawi Hazzan. Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03852-9
29
Federica Fascì-Spurio, Polychronis Pavlidis, Ingvar Bjarnason. A new form of chronic inflammatory bowel disease associated with chronic liver disease. Scandinavian Journal of Gastroenterology 2016; 51(6) doi: 10.3109/00365521.2015.1128141
30
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020;  doi: 10.1017/9781316823026
31
Tommaso D’Angelo, Silvio Mazziotti, Alfredo Blandino, Giuseppe Cicero. MR Enterography. 2022;  doi: 10.1007/978-3-031-11930-9_6
32
Juliana Silva, Beatriz S. Brito, Isaac Neri de N. Silva, Viviane G. Nóbrega, Maria Carolina S. M. da Silva, Hemerson Dyego de N. Gomes, Flora Maria Fortes, Andrea M. Pimentel, Jaciane Mota, Neogélia Almeida, Valdiana C. Surlo, André Lyra, Raquel Rocha, Genoile O. Santana. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. BioMed Research International 2019; 2019 doi: 10.1155/2019/7604939
33
Erik von Seth, Tom H Karlsen, Atsushi Tanaka, Cyriel Ponsioen, Annika Bergquist. Primary sclerosing cholangitis. The Lancet 2026; 407(10538) doi: 10.1016/S0140-6736(25)02582-6
34
Dongyuan Zheng, Qinke Xu, Jin Wu, Zhouyue Gu, Jieya Chen, Yingchao Liu. Prevalence and bidirectional association between primary sclerosing cholangitis and Crohn's disease: A systematic review and meta-analysis. Gastroenterología y Hepatología (English Edition) 2025; 48(8) doi: 10.1016/j.gastre.2025.502346
35
Kate D. Lynch, Roger W. Chapman, Satish Keshav, Aldo J. Montano-Loza, Andrew L. Mason, Andreas E. Kremer, Marcel Vetter, Manon de Krijger, Cyriel Y. Ponsioen, Palak Trivedi, Gideon Hirschfield, Christoph Schramm, Chung Heng Liu, Christopher L. Bowlus, Derek J. Estes, Daniel Pratt, Charlotte Hedin, Annika Bergquist, Annemarie C. de Vries, C. Janneke van der Woude, Lei Yu, David N. Assis, James Boyer, Henriette Ytting, Emina Hallibasic, Michael Trauner, Hanns-Ulrich Marschall, Luigi M. Daretti, Marco Marzioni, Kidist K. Yimam, Nicola Perin, Annarosa Floreani, Benedetta Terziroli Beretta-Piccoli, Jennifer K. Rogers, Cynthia Levy. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2020; 18(1) doi: 10.1016/j.cgh.2019.05.013
36
David Ellinghaus. How genetic risk contributes to autoimmune liver disease. Seminars in Immunopathology 2022; 44(4) doi: 10.1007/s00281-022-00950-8
37
Marcial Sebode, Heike Bantel, Ulrich Baumann, Philip Bufler, Münevver Demir, Leona Dold, Verena Keitel-Anselmino, Reinhild Klein, Andreas E. Kremer, Petra L. Jansen, Michael Melter, Peter Schirmacher, Christoph Schramm, Martina Sterneck, Christian P. Strassburg, Christina Weiler-Normann, Ansgar W. Lohse. Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline. Zeitschrift für Gastroenterologie 2026; 64(05) doi: 10.1055/a-2769-2475
38
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1) doi: 10.21508/1027-4065-2021-66-1-39-46
39
Ludwig J. Horst, Jan Kempski, Martine Walmsley, Samuel Huber, Christoph Schramm. PSC and colitis: A complex relationship. Hepatology 2025; 82(4) doi: 10.1097/HEP.0000000000001236
40
Mohammad Mawardi, Abduljaleel Alalwan, Hind Fallatah, Faisal Abaalkhail, Mohammed Hasosah, Mohammad Shagrani, Mohammed Y Alghamdi, Abdullah S Alghamdi. Cholestatic liver disease. Saudi Journal of Gastroenterology 2021; 27(Suppl 1) doi: 10.4103/sjg.sjg_112_21
41
Emily Read, Michael A. Curtis, Joana F. Neves. The role of oral bacteria in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 2021; 18(10) doi: 10.1038/s41575-021-00488-4
42
Kristel K. Leung, Maya Deeb, Sandra E. Fischer, Aliya Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Seminars in Liver Disease 2021; 41(03) doi: 10.1055/s-0041-1730950
43
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado. Gastroenterología y Hepatología 2019; 42(5) doi: 10.1016/j.gastrohep.2019.02.004
44
Maysoon Gamaleldin, Luca Stocchi. Surgical Procedures on the Cirrhotic Patient. 2017;  doi: 10.1007/978-3-319-52396-5_15
45
Nguyen Phung Vo, Anh Ho, Linh Ho. Nanocarriers Based Colon Targeting. 2025;  doi: 10.1016/B978-0-443-24806-1.00017-0
46
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020;  doi: 10.1017/9781316823026.022
47
Martin Gregor, Julius Spicak, Michal Kahle, Petra Novotna, Mojmir Hlavaty, Pavel Drastich, Jan Brezina, Lukas Bajer, Ondrej Fabian, Petr Wohl, Alzbeta Krausova, Pavel Wohl. Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis. World Journal of Gastrointestinal Endoscopy 2024; 16(11): 607-616 doi: 10.4253/wjge.v16.i11.607
48
Olga V. Usoltseva, Andrey N. Surkov, Goar B. Movsisyan, Elena A. Kulebina, Svetlana A. Simersina, Alexander S. Potapov, Maksim M. Lokhmatov. Primary sclerosing cholangitis in children with inflammatory bowel disease. Russian Pediatric Journal 2022; 24(6) doi: 10.46563/1560-9561-2021-24-6-395-404
49
Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, Gunn Huh, Ce Hwan Park, Sang Hyub Lee, Heon Se Jeong, Hee Jin Kim, Do Hyun Park. Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial. Clinical and Molecular Hepatology 2025; 31(1) doi: 10.3350/cmh.2024.0629
50
Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei. Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease. Intestinal Research 2022; 20(2) doi: 10.5217/ir.2021.00042
51
Kevin De Muynck, Lindsey Devisscher. Targeting osteopontin to treat primary sclerosing cholangitis. Current Opinion in Gastroenterology 2024; 40(2) doi: 10.1097/MOG.0000000000001001
52
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease. 2023;  doi: 10.1007/978-3-031-14744-9_11
53
Amanda Ricciuto, Bettina E. Hansen, Brian Ngo, Marina Aloi, Thomas D. Walters, Peter C. Church, Abigail Mazurek, Maryam Khan, Nicholas Carman, Iram Siddiqui, Geoffrey C. Nguyen, Binita M. Kamath, Anne M. Griffiths. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment. Clinical Gastroenterology and Hepatology 2020; 18(7) doi: 10.1016/j.cgh.2019.08.048
54
Fatemeh Hadizadeh, Charlie W. Lees, Catherine Labbé, John D. Rioux, Miles Parkes, Alexandra Zhernakova, Andre Franke, Charlotte Hedin, Mauro D’Amato. Molecular Genetics of Inflammatory Bowel Disease. 2019;  doi: 10.1007/978-3-030-28703-0_5
55
Britta Siegmund. Chronisch-entzündliche Darmerkrankungen. 2020;  doi: 10.1007/978-3-662-59104-8_3
56
Keisuke Hata, Soichiro Ishihara, Hiroaki Nozawa, Kazushige Kawai, Tomomichi Kiyomatsu, Toshiaki Tanaka, Junko Kishikawa, Hiroyuki Anzai, Toshiaki Watanabe. Pouchitis after ileal pouch‐anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence. Digestive Endoscopy 2017; 29(1) doi: 10.1111/den.12744
57
Kristel K. Leung, Wenbin Li, Bettina Hansen, Aliya Gulamhusein, Lauren Lapointe-Shaw, Abdel Aziz Shaheen, Amanda Ricciuto, Eric I. Benchimol, Jennifer A. Flemming, Gideon M. Hirschfield. Primary sclerosing cholangitis–inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence. JHEP Reports 2025; 7(3) doi: 10.1016/j.jhepr.2024.101272
58
Roberto Grassia, Andrea Drago, Fabrizio Cereatti, Francesca Ferretti, Biagio Elvo, Maria Chiara Verga, Sara Soro, Stefano Mazza. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
59
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis. Experimental & Molecular Medicine 2023; 55(7) doi: 10.1038/s12276-023-01042-9
60
Johanna Eliasson, Bobby Lo, Christoph Schramm, Olivier Chazouilleres, Trine Folseraas, Ulrich Beuers, Henriette Ytting. Survey uncovering variations in the management of primary sclerosing cholangitis across Europe. JHEP Reports 2022; 4(11) doi: 10.1016/j.jhepr.2022.100553
61
Dominika Suchecka, Joanna Harasym, Jacek Wilczak, Joanna Gromadzka-Ostrowska. Hepato- and gastro- protective activity of purified oat 1–3, 1–4-β- d -glucans of different molecular weight. International Journal of Biological Macromolecules 2016; 91 doi: 10.1016/j.ijbiomac.2016.06.062
62
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park. Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study. Intestinal Research 2023; 21(2) doi: 10.5217/ir.2022.00092
63
Shaun R. Brown, Lisa C. Coviello. Extraintestinal Manifestations Associated with Inflammatory Bowel Disease. Surgical Clinics of North America 2015; 95(6) doi: 10.1016/j.suc.2015.08.002
64
Meysam Olfatifar, Mohsen Rajabnia, Amir Sadeghi, Amirhassan Rabbani, Shabnam Shahrokh, Mohammad Amin Habibi, MehdiSure Pezeshgi Modarres, Mohammad Reza Zali, Hamidreza Houri, Maher Abdelraheim Titi. The epidemiological trends and projected future of primary sclerosing cholangitis by 2040: An updated meta-analysis and modeling study. PLOS One 2025; 20(5) doi: 10.1371/journal.pone.0322479
65
Malte Rühlemann, Timur Liwinski, Femke‐Anouska Heinsen, Corinna Bang, Roman Zenouzi, Martin Kummen, Louise Thingholm, Marie Tempel, Wolfgang Lieb, Tom Karlsen, Ansgar Lohse, Johannes Hov, Gerald Denk, Frank Lammert, Marcin Krawczyk, Christoph Schramm, Andre Franke. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Alimentary Pharmacology & Therapeutics 2019; 50(5) doi: 10.1111/apt.15375
66
Henry Shiau, Faith D. Ihekweazu, Mansi Amin, Tatiana Fofanova, Tamir Miloh, Richard Kellermayer. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis. Journal of Pediatric Gastroenterology and Nutrition 2017; 65(4) doi: 10.1097/MPG.0000000000001531
67
Takuya Yoshino, Hiroshi Nakase, Tomohisa Takagi, Shigeki Bamba, Yusuke Okuyama, Takuji Kawamura, Teruki Oki, Hirozumi Obata, Chiharu Kawanami, Shinji Katsushima, Toshihiro Kusaka, Tomoyuki Tsujikawa, Yuji Naito, Akira Andoh, Takafumi Kogawa. Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I. BMJ Open Gastroenterology 2016; 3(1) doi: 10.1136/bmjgast-2016-000122
68
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
69
Kelly Vo, Leandro Sierra, Karimar Amador-Martinez, Nikki Duong. Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample. BMJ Open 2026; 16(2) doi: 10.1136/bmjopen-2025-106184
70
Bejan J. Saeedi, Lisa M. Forman. Malignancy Screening in Primary Sclerosing Cholangitis. Current Hepatology Reports 2026; 25(1) doi: 10.1007/s11901-025-00717-3
71
Manon de Krijger, Manon E. Wildenberg, Wouter J. de Jonge, Cyriel Y. Ponsioen. Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis. Journal of Hepatology 2019; 71(3) doi: 10.1016/j.jhep.2019.05.006
72
Hiep Nguyen Canh, Kenichi Harada. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma. Medical Molecular Morphology 2016; 49(4) doi: 10.1007/s00795-016-0143-6
73
Morten L Halling, Jens Kjeldsen, Torben Knudsen, Jan Nielsen, Lars Koch Hansen. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World Journal of Gastroenterology 2017; 23(33): 6137-6146 doi: 10.3748/wjg.v23.i33.6137
74
Saqr Alsakarneh, Razan Aburumman, Mohammad Bilal, Adam S. Faye, Jana G. Hashash, Aasma Shaukat. Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis. Alimentary Pharmacology & Therapeutics 2025; 62(11-12) doi: 10.1111/apt.70303
75
Sabina Wiecek, Alicja Wojtyniak, Barbara Pindur, Magdalena Machnikowska-Sokołowska, Katarzyna Gruszczyńska, Urszula Grzybowska-Chlebowczyk. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population—Single Center Study. Medicina 2021; 57(7) doi: 10.3390/medicina57070663
76
Felix Solberg, Bodil Ohlsson. Microscopic colitis and its associations with complications observed in classic inflammatory bowel disease: a systematic review. Scandinavian Journal of Gastroenterology 2020; 55(3) doi: 10.1080/00365521.2020.1739325
77
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A review. World Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956
78
Sabina Wiecek. Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy. 2022;  doi: 10.5772/intechopen.102080
79
Taku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, Haruhiko Ogata, Akira Andoh, Toshimitsu Araki, Ryota Hokari, Hideki Iijima, Hiroki Ikeuchi, Yoh Ishiguro, Shingo Kato, Reiko Kunisaki, Takayuki Matsumoto, Satoshi Motoya, Masakazu Nagahori, Shiro Nakamura, Hiroshi Nakase, Tomoyuki Tsujikawa, Makoto Sasaki, Kaoru Yokoyama, Naoki Yoshimura, Kenji Watanabe, Miiko Katafuchi, Mamoru Watanabe, Toshifumi Hibi. Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries. Intestinal Research 2018; 16(2) doi: 10.5217/ir.2018.16.2.168
80
Sabina Wiecek. Hepatitis A and Other Associated Hepatobiliary Diseases. 2020;  doi: 10.5772/intechopen.90714
81
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2024; 28(1) doi: 10.1016/j.cld.2023.07.005
82
Lídia Roque Ramos, Christopher J. DiMaio, David B. Sachar, Ashish Atreja, Jean-Frédéric Colombel, Joana Torres. Autoimmune pancreatitis and inflammatory bowel disease: Case series and review of the literature. Digestive and Liver Disease 2016; 48(8) doi: 10.1016/j.dld.2016.05.008
83
Trevor J Laborda, M Kyle Jensen, Marianne Kavan, Mark Deneau. Treatment of primary sclerosing cholangitis in children. World Journal of Hepatology 2019; 11(1): 19-36 doi: 10.4254/wjh.v11.i1.19
84
Claire Kelly, Yoh Zen, Michael A. Heneghan. Post-Transplant Immunosuppression in Autoimmune Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(2) doi: 10.1016/j.jceh.2022.07.002
85
MT Ko, A Hammodi. How to approach jaundice in the MRCP PACES exam. British Journal of Hospital Medicine 2023; 84(2) doi: 10.12968/hmed.2022.0438
86
Hanghang Wu, Chaobo Chen, Siham Ziani, Leonard J. Nelson, Matías A. Ávila, Yulia A. Nevzorova, Francisco Javier Cubero. Fibrotic Events in the Progression of Cholestatic Liver Disease. Cells 2021; 10(5) doi: 10.3390/cells10051107
87
Sara Massironi, Fabrizio Fanizzi, Federica Invernizzi, Federica Furfaro, Lorenzo Ciocca, Ivan Arcari, Mariangela Allocca, Laurent Peyrin-Biroulet, Silvio Danese. Inflammatory bowel disease and primary sclerosing cholangitis: immunological links and clinical outlook. Expert Review of Clinical Immunology 2026; 22(4) doi: 10.1080/1744666X.2026.2664055
88
John M. Vierling. Primary Sclerosing Cholangitis. 2017;  doi: 10.1007/978-3-319-40908-5_9
89
Peter Laszlo Ven, David Tornai, Bence Toth, Zsuzsanna Vitalis, Istvan Tornai, Tamas Tornai, Gabriella Par, Maria Papp. Longitudinal Comparison of Currently Used Risk Scores for Prognostication of Primary Sclerosing Cholangitis (PSC) in a Hungarian Bicenter PSC Cohort. Diagnostics 2025; 15(17) doi: 10.3390/diagnostics15172166
90
Miah Lingelbach, Tobias Keck, Aiste Gulla. Rare Liver and Biliary Tract Diseases. 2026;  doi: 10.1007/978-3-032-15076-9_31
91
Chuan Liu, Rong Yu, Jixiang Zhang, Shuchun Wei, Fumin Xue, Yingyun Guo, Pengzhan He, Lining Shang, Weiguo Dong. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.972079
92
Luca Maroni, Elisabetta Ninfole, Claudio Pinto, Antonio Benedetti, Marco Marzioni. Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology. Cells 2020; 9(3) doi: 10.3390/cells9030736
93
Haoran Shi, Dan Dou, Fangyi Zhang, Yanhong Du, Lu Zhao, Jing Zhi, Luqing Zhao. Prevalence and Bidirectional Association Between Autoimmune Liver Disease and Inflammatory Bowel Disease: A Meta‐Analysis. Journal of Gastroenterology and Hepatology 2025; 40(10) doi: 10.1111/jgh.70018
94
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 2021; 161(6) doi: 10.1053/j.gastro.2021.07.046
95
Kim N. van Munster, Annika Bergquist, Cyriel Y. Ponsioen. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?. Journal of Hepatology 2024; 80(1) doi: 10.1016/j.jhep.2023.09.031
96
Armando Curto, Laura Cristoferi, Marco Carbone, Andrea Galli, Pietro Invernizzi. Primary sclerosing cholangitis: what is new in the therapeutic landscape. Current Opinion in Immunology 2025; 96 doi: 10.1016/j.coi.2025.102613
97
Bence Kővári, Rish K. Pai. Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls. Advances in Anatomic Pathology 2022; 29(1) doi: 10.1097/PAP.0000000000000311
98
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 2023; 13(3) doi: 10.3390/metabo13030378
99
Xiaoyong Xue, Jianzhi Wu, Mingning Ding, Feng Gao, Fei Zhou, Bing Xu, Mingjun Lu, Jun Li, Xiaojiaoyang Li. Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis. Chinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00524-0
100
Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBD. Current Gastroenterology Reports 2018; 20(4) doi: 10.1007/s11894-018-0620-2
101
Rinse K. Weersma, Keith D. Lindor. Shifting Paradigms: What Is the True Prevalence and Clinical Course of Primary Sclerosing Cholangitis?. Gastroenterology 2016; 151(4) doi: 10.1053/j.gastro.2016.08.046
102
Kai Markus Schneider, Lena Susanna Candels, Johannes R. Hov, Maiju Myllys, Reham Hassan, Carolin Victoria Schneider, Annika Wahlström, Antje Mohs, Sebastian Zühlke, Lijun Liao, Carsten Elfers, Konrad Kilic, Marcus Henricsson, Antonio Molinaro, Maximilian Hatting, Ayham Zaza, Dirk Drasdo, Mick Frissen, A. Sloan Devlin, Eric J. C. Gálvez, Till Strowig, Tom H. Karlsen, Jan G. Hengstler, Hanns-Ulrich Marschall, Ahmed Ghallab, Christian Trautwein. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling. Nature Metabolism 2021; 3(9) doi: 10.1038/s42255-021-00452-1
103
Ruth Zhang, Dongliang Wang, Gregory Y. Lauwers, Won-Tak Choi. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. American Journal of Surgical Pathology 2024; 48(9) doi: 10.1097/PAS.0000000000002255
104
S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Zeitschrift für Gastroenterologie 2025; 63(06) doi: 10.1055/a-2558-5204
105
Johan Vessby, Maria Lampinen, Mikael Åberg, Fredrik Rorsman, Agneta Siegbahn, Alkwin Wanders, Marie Carlson. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis. Upsala Journal of Medical Sciences 2019; 124(4) doi: 10.1080/03009734.2019.1689209
106
David Ellinghaus, Luke Jostins, Sarah L Spain, Adrian Cortes, Jörn Bethune, Buhm Han, Yu Rang Park, Soumya Raychaudhuri, Jennie G Pouget, Matthias Hübenthal, Trine Folseraas, Yunpeng Wang, Tonu Esko, Andres Metspalu, Harm-Jan Westra, Lude Franke, Tune H Pers, Rinse K Weersma, Valerie Collij, Mauro D'Amato, Jonas Halfvarson, Anders Boeck Jensen, Wolfgang Lieb, Franziska Degenhardt, Andreas J Forstner, Andrea Hofmann, Stefan Schreiber, Ulrich Mrowietz, Brian D Juran, Konstantinos N Lazaridis, Søren Brunak, Anders M Dale, Richard C Trembath, Stephan Weidinger, Michael Weichenthal, Eva Ellinghaus, James T Elder, Jonathan N W N Barker, Ole A Andreassen, Dermot P McGovern, Tom H Karlsen, Jeffrey C Barrett, Miles Parkes, Matthew A Brown, Andre Franke. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nature Genetics 2016; 48(5) doi: 10.1038/ng.3528
107
Ming-Hsi Wang, Omar Y Mousa, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly C Cushing, Kelly Monroe, Billy D Nix, Rodney D Newberry, William A Faubion. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience. Inflammatory Bowel Diseases 2020; 26(5) doi: 10.1093/ibd/izz209
108
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entity. Expert Review of Gastroenterology & Hepatology 2022; 16(2) doi: 10.1080/17474124.2022.2031979
109
Michael F. McGee, Scott A. Strong. Inflammatory, infectious, and ischemic disorders of the pelvic pouch. Seminars in Colon and Rectal Surgery 2019; 30(1) doi: 10.1053/j.scrs.2019.01.004
110
Tej I. Mehta, Simcha Weissman, Brian M. Fung, John Sotiriadis, Keith D. Lindor, James H. Tabibian. Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta‐analysis. Liver International 2021; 41(10) doi: 10.1111/liv.15007
111
Pooya Jalali, Malihe Rezaee, Alireza Yaghoobi, Moein Piroozkhah, Mohammad Reza Zabihi, Shahram Aliyari, Zahra Salehi. Bioinformatics analysis reveals shared molecular pathways for relationship between ulcerative colitis and primary sclerosing cholangitis. Genomics & Informatics 2025; 23(1) doi: 10.1186/s44342-025-00045-4
112
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3) doi: 10.1016/j.jhep.2022.05.011
113
Magali Svrcek, Paula Borralho Nunes, Vincenzo Villanacci, Laurent Beaugerie, Gerhard Rogler, Gert De Hertogh, Monika Tripathi, Roger Feakins. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease–Related Colorectal Neoplastic Lesions: The Role of Inflammation. Journal of Crohn's and Colitis 2018;  doi: 10.1093/ecco-jcc/jjy132
114
Mike Van Der Have, Bas Oldenburg. Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?. Inflammatory Bowel Diseases 2020; 26(5) doi: 10.1093/ibd/izz211
115
Brigid Pinnuck, Kate D. Lynch. Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis. Expert Opinion on Pharmacotherapy 2024; 25(13) doi: 10.1080/14656566.2024.2407022
116
Tanja Bedke, Friederike Stumme, Miriam Tomczak, Babett Steglich, Rongrong Jia, Simon Bohmann, Agnes Wittek, Jan Kempski, Emilia Göke, Marius Böttcher, Dominik Reher, Anissa Franke, Maximilian Lennartz, Till Clauditz, Guido Sauter, Thorben Fründt, Sören Weidemann, Gisa Tiegs, Christoph Schramm, Nicola Gagliani, Penelope Pelczar, Samuel Huber. Protective function of sclerosing cholangitis on IBD. Gut 2024; 73(8) doi: 10.1136/gutjnl-2023-330856
117
Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2026;  doi: 10.1016/B978-0-443-29172-2.00012-0
118
Ludwig J. Leß-Horst, Christoph Schramm. Primär sklerosierende Cholangitis und chronisch-entzündliche Darmerkrankung: Darm-Leber-Achse als Schlüssel zur primär sklerosierenden Cholangitis. Deutsches Ärzteblatt Online 2026;  doi: 10.3238/PersGastro.2026.04.03.01
119
Richard Kellermayer. Should all pediatric patients with type 1 autoimmune hepatitis be screened for inflammatory bowel disease?. JHEP Reports 2025; 7(3) doi: 10.1016/j.jhepr.2024.101291
120
Romelia Barba Bernal, Esli Medina-Morales, Daniela Goyes, Vilas Patwardhan, Alan Bonder. Management of Autoimmune Liver Diseases after Liver Transplantation. Transplantology 2021; 2(2) doi: 10.3390/transplantology2020016
121
Remi Mahmoud, Shailja C. Shah, Joren R. ten Hove, Joana Torres, Erik Mooiweer, Daniel Castaneda, Jason Glass, Jordan Elman, Akash Kumar, Jordan Axelrad, Thomas Ullman, Jean-Frederic Colombel, Bas Oldenburg, Steven H. Itzkowitz. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases. Gastroenterology 2019; 156(5) doi: 10.1053/j.gastro.2018.11.067
122
Petronela Nicoleta Seritean Isac, Diana Popescu, Tudor Marcel Genes, Minerva Codruta Badescu, Ioana Irina Rezus, Nicoleta Dima, Ana Roxana Rusu Ganceanu, Elena Rezus, Ciprian Rezus. Etiopathogenic and Clinical Aspects in Inflammatory Bowel Disease – Literature Review. Journal of Interdisciplinary Medicine 2021; 6(3) doi: 10.2478/jim-2021-0031
123
Burak Demir, Elgin Özkan, Seda Kaynak Şahap, Gizem Sütçü, Ceyda Tuna Kırsaçlıoğlu, Çiğdem Soydal, Ömer Suat Fitoz, Aydan Kansu Tanca, Emel Ünal. A Rare Case of “Periportal Cuffing” as an Incidental Finding on <sup>18</sup>F-FDG PET/CT. Molecular Imaging and Radionuclide Therapy 2023; 32(3) doi: 10.4274/mirt.galenos.2023.53254
124
Álvaro Díaz-González, Cristina Molera, Elena Gómez-Domínguez, Gema Muñoz-Bartolo, Javier Ampuero, Conrado Fernández-Rodríguez, Jesus Quintero, Esther Molina, Magdalena Salcedo, Antonio Olveira, Rosa Morillas, María Alós Díez, Marta Casado, Luisa García-Buey, Sergio Rodríguez-Tajes, Francisco Jorquera, Marina Berenguer, Jose Luis Montero, Maria Carlota Londoño. Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP. Gastroenterología y Hepatología 2026; 49(4) doi: 10.1016/j.gastrohep.2025.502629
125
Dongyuan Zheng, Qinke Xu, Jin Wu, Zhouyue Gu, Jieya Chen, Yingchao Liu. Prevalence and bidirectional association between primary sclerosing cholangitis and Crohn's disease: A systematic review and meta-analysis. Gastroenterología y Hepatología 2025; 48(8) doi: 10.1016/j.gastrohep.2025.502346
126
Blair Fennimore, Emilie H. Regner, Mark E. Gerich. Primary Sclerosing Cholangitis. 2017;  doi: 10.1007/978-3-319-40908-5_3
127
Lauren Van Der Kraak, Philippe Gros, Nicole Beauchemin. Colitis-associated colon cancer: Is it in your genes?. World Journal of Gastroenterology 2015; 21(41): 11688-11699 doi: 10.3748/wjg.v21.i41.11688
128
Brian H. Horwich, Douglas T. Dieterich. Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis. Clinics in Liver Disease 2024; 28(1) doi: 10.1016/j.cld.2023.07.006
129
Sreelakshmi Kotha, Ioannis Koumoutsos, Ben Warner, Eleni Theocharidou, Joel Mawdsley, Philip Berry. Setting up an integrated service for PSC-IBD patients: A quality improvement project. iLIVER 2024; 3(2) doi: 10.1016/j.iliver.2024.100076
130
Arshdeep Singh, Vandana Midha, Vikram Narang, Saurabh Kedia, Ramit Mahajan, Pavan Dhoble, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Ashish Tripathi, Shivam Kalra, Narender Pal Jain, Namita Bansal, Rupa Banerjee, Devendra Desai, Usha Dutta, Vineet Ahuja, Ajit Sood. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India. Intestinal Research 2023; 21(4) doi: 10.5217/ir.2022.00087
131
Pilar López Serrano, Juan Turnes Vázquez. Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunity. Revista Española de Enfermedades Digestivas 2020; 112 doi: 10.17235/reed.2020.7512/2020
132
Nilanga Nishad, Madunil Anuk Niriella, Arjuna P. de Silva, Kimberley Butler, Sreedhar Subramanian, Mo Hameed Thoufeeq. The Interrelationship Between Small Duct PSC And Large Duct PSC: Diagnostic Challenges, Genetic Insights, And Prognostic Implications; a Narrative Review. Current Hepatology Reports 2025; 24(1) doi: 10.1007/s11901-025-00705-7
133
Roger M Feakins. Morson and Dawson's Gastrointestinal Pathology. 2024;  doi: 10.1002/9781119423195.ch35
134
Amr Sayed, David N. Assis, Marina G. Silveira, Yanhong Deng, Maria Ciarleglio, Jill K.J. Gaidos, Deborah D. Proctor, Badr Al-Bawardy. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2023; 35(3) doi: 10.1097/MEG.0000000000002510
135
Sheena Mago, George Y. Wu. Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review. Journal of Clinical and Translational Hepatology 2020; 8(3) doi: 10.14218/JCTH.2020.00036
136
Ruth Zhang, Gregory Y Lauwers, Won-Tak Choi. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(12) doi: 10.1093/ecco-jcc/jjac090
137
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut and Liver 2018; 12(1) doi: 10.5009/gnl16510
138
Way Seah Lee, Sivaramakrishnan Venkatesh Karthik, Ruey Terng Ng, Sik Yong Ong, Christina Ong, Fang K. Chiou, Shin Yee Wong, Seng Hock Quak, Marion Margaret Aw. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children. Pediatrics & Neonatology 2019; 60(4) doi: 10.1016/j.pedneo.2018.09.007
139
Josiah D. McCain, David M. Chascsa, Keith D. Lindor. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients. Expert Opinion on Orphan Drugs 2021; 9(2) doi: 10.1080/21678707.2021.1898370
140
Marin J. de Jong, Jiangrong Zhou, Lauranne A.A.P. Derikx, S. Darwish Murad, Adriaan J. van der Meer, Annemarie C. de Vries. Management of Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis Pre- and Post-liver Transplantation. Transplantation 2026; 110(3) doi: 10.1097/TP.0000000000005607
141
Bence Kővári, Ágnes Báthori, Mark S. Friedman, Gregory Y. Lauwers. Histologic Diagnosis of Inflammatory Bowel Diseases. Advances in Anatomic Pathology 2022; 29(1) doi: 10.1097/PAP.0000000000000325
142
Cristian Camilo Villa-Gómez, Daniel Stiven Velilla-Aguirre, Laura Camila Lopera-Restrepo, Sergio Iván Hoyos-Duque. Colangitis esclerosante primaria. Una revisión narrativa. Iatreia 2020; 33(3) doi: 10.17533/udea.iatreia.57
143
Kate D. Lynch, Satish Keshav, Roger W. Chapman. The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Current Hepatology Reports 2019; 18(1) doi: 10.1007/s11901-019-00456-2
144
Arash Motamed, Thang Tran, Mohamed H. Eloustaz. Obstetric Anesthesia and Uncommon Disorders. 2024;  doi: 10.1017/9781009070256.019
145
Katie Ann Dunleavy, Priscila Santiago, Gerard Forde, W Scott Harmsen, Nicholas P McKenna, Nayantara Coelho-Prabhu, Sherief Shawki, Laura Raffals. Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2024; 30(11) doi: 10.1093/ibd/izad278
146
Britta F. Zecher, Christoph Schramm. Immunpathogenese und Therapie der Primär Sklerosierenden Cholangitis. Zeitschrift für Gastroenterologie 2026; 64(01) doi: 10.1055/a-2730-4719
147
Sabrina Cardile, Tommaso Alterio, Manila Candusso, Andrea Pietrobattista, Daniela Liccardo, Maria Sole Basso, Bronislava Papadatou, Fiammetta Bracci, Daniela Knafelz, Giuliano Torre. Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives. Scandinavian Journal of Gastroenterology 2017; 52(6-7) doi: 10.1080/00365521.2017.1298833
148
Souvik Sarkar, Christopher L. Bowlus. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2016; 20(1) doi: 10.1016/j.cld.2015.08.005
149
Umer Malik, Bilal Ashraf, Sonia B. Samuel, Stephen Hasak. GI Diseases Associated with Rheumatological and Vasculitic Conditions. Clinical Gastroenterology 2025;  doi: 10.1007/978-3-032-07868-1_12
150
Jessica M. Ferrell. Circadian rhythms and inflammatory diseases of the liver and gut. Liver Research 2023; 7(3) doi: 10.1016/j.livres.2023.08.004
151
Álvaro Díaz-González, Cristina Molera, Elena Gómez-Domínguez, Gema Muñoz-Bartolo, Javier Ampuero, Conrado Fernández-Rodríguez, Jesus Quintero, Esther Molina, Magdalena Salcedo, Antonio Olveira, Rosa Morillas, María Alós Díez, Marta Casado, Luisa García-Buey, Sergio Rodríguez-Tajes, Francisco Jorquera, Marina Berenguer, Jose Luis Montero, Maria Carlota Londoño. Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP. Gastroenterología y Hepatología (English Edition) 2026; 49(4) doi: 10.1016/j.gastre.2026.502629
152
Matteo PEVIANI, Nora CAZZAGON, Martina GAMBATO, Luisa BERTIN, Fabiana ZINGONE, Edoardo V. SAVARINO, Brigida BARBERIO. Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship. Minerva Gastroenterology 2025; 71(1) doi: 10.23736/S2724-5985.23.03605-7
153
Istvan Fedor, Eva Zold, Zsolt Barta. Contrasting Autoimmune Comorbidities in Microscopic Colitis and Inflammatory Bowel Diseases. Life 2023; 13(3) doi: 10.3390/life13030652
154
Shailja C. Shah, Joren R. ten Hove, Daniel Castaneda, Carolina Palmela, Erik Mooiweer, Jean-Frédéric Colombel, Noam Harpaz, Thomas A. Ullman, Ad A. van Bodegraven, Jeroen M. Jansen, Nofel Mahmmod, Andrea E. van der Meulen-de Jong, Cyriel Y. Ponsioen, Christine J. van der Woude, Bas Oldenburg, Steven H. Itzkowitz, Joana Torres. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 2018; 16(7) doi: 10.1016/j.cgh.2018.01.023
155
Nan Wu, Fanyin Meng, Pietro Invernizzi, Francesca Bernuzzi, Julie Venter, Holly Standeford, Paolo Onori, Marco Marzioni, Domenico Alvaro, Antonio Franchitto, Eugenio Gaudio, Shannon Glaser, Gianfranco Alpini. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor‐β1 biliary secretion in mice. Hepatology 2016; 64(3) doi: 10.1002/hep.28622
156
Alexander J. Kovalic, Herbert L. Bonkovsky. Diagnosis and Management of Autoimmune Hepatitis. 2020;  doi: 10.1007/978-3-030-33628-8_2
157
Brigida Barberio, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford, Edoardo V. Savarino. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology 2021; 161(6) doi: 10.1053/j.gastro.2021.08.032
158
Girak Kim, Zuojia Chen, Jian Li, Jialie Luo, Felipe Castro-Martinez, Jan Wisniewski, Kairong Cui, Yan Wang, Jialei Sun, Xiaobai Ren, Susan E. Crawford, S. Patricia Becerra, Jimin Zhu, Taotao Liu, Sui Wang, Keji Zhao, Chuan Wu. Gut-liver axis calibrates intestinal stem cell fitness. Cell 2024; 187(4) doi: 10.1016/j.cell.2024.01.001
159
Federica Del Chierico, Sabrina Cardile, Valerio Baldelli, Tommaso Alterio, Sofia Reddel, Matteo Bramuzzo, Daniela Knafelz, Sara Lega, Fiammetta Bracci, Giuliano Torre, Giuseppe Maggiore, Lorenza Putignani. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. Inflammatory Bowel Diseases 2024; 30(4) doi: 10.1093/ibd/izad203
160
Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. International Journal of Molecular Sciences 2021; 22(13) doi: 10.3390/ijms22136975
161
Sun-Gou Ji, Brian D Juran, Sören Mucha, Trine Folseraas, Luke Jostins, Espen Melum, Natsuhiko Kumasaka, Elizabeth J Atkinson, Erik M Schlicht, Jimmy Z Liu, Tejas Shah, Javier Gutierrez-Achury, Kirsten M Boberg, Annika Bergquist, Severine Vermeire, Bertus Eksteen, Peter R Durie, Martti Farkkila, Tobias Müller, Christoph Schramm, Martina Sterneck, Tobias J Weismüller, Daniel N Gotthardt, David Ellinghaus, Felix Braun, Andreas Teufel, Mattias Laudes, Wolfgang Lieb, Gunnar Jacobs, Ulrich Beuers, Rinse K Weersma, Cisca Wijmenga, Hanns-Ulrich Marschall, Piotr Milkiewicz, Albert Pares, Kimmo Kontula, Olivier Chazouillères, Pietro Invernizzi, Elizabeth Goode, Kelly Spiess, Carmel Moore, Jennifer Sambrook, Willem H Ouwehand, David J Roberts, John Danesh, Annarosa Floreani, Aliya F Gulamhusein, John E Eaton, Stefan Schreiber, Catalina Coltescu, Christopher L Bowlus, Velimir A Luketic, Joseph A Odin, Kapil B Chopra, Kris V Kowdley, Naga Chalasani, Michael P Manns, Brijesh Srivastava, George Mells, Richard N Sandford, Graeme Alexander, Daniel J Gaffney, Roger W Chapman, Gideon M Hirschfield, Mariza de Andrade, Simon M Rushbrook, Andre Franke, Tom H Karlsen, Konstantinos N Lazaridis, Carl A Anderson. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nature Genetics 2017; 49(2) doi: 10.1038/ng.3745
162
E V Vinnitskaya, S R Abdulkhakov, D T Abdurakhmanov, R B Alikhanov, I G Bakulin, E A Belousova, A O Bueverov, E Z Burnevitch, M G Efanov, E Yu Eremina, T M Ignatova, L Yu Ilchenko, G G Karmazanovsky, O V Knyazev, Yu V Kulezneva, T N Lopatkina, T P Nekrasova, I G Nikitin, V V Pavlenko, A I Parfenov, S D Podymova, K L Raichelson, A R Reisis, R G Sayfutdinov, E V Skazyvaeva, V E Syutkin, S G Khomeriki, T Yu Haimenova, Yu G Sandler. Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018). Terapevticheskii arkhiv 2019; 91(2) doi: 10.26442/00403660.2019.02.000075
163
Rodrigo V Motta, Vipin Gupta, Karen Hartery, Paul Bassett, Simon J Leedham, Roger W Chapman, Simon PL Travis, Emma L Culver, James E. East. Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD. Endoscopy International Open 2024; 12(11) doi: 10.1055/a-2437-8102
164
Mindy C Ward, Blake Studer, Ian Nora, Nathan Seepaulsing, Charles Loewe. Primary Sclerosing Cholangitis in Crohn’s Disease: An Atypical Complication. Cureus 2021;  doi: 10.7759/cureus.14964
165
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation. Gastroenterología y Hepatología (English Edition) 2019; 42(5) doi: 10.1016/j.gastre.2019.02.030
166
Friederike Stumme, Niklas Steffens, Babett Steglich, Franziska Mathies, Mikolaj Nawrocki, Morsal Sabihi, Shiwa Soukou-Wargalla, Emilia Göke, Jan Kempski, Thorben Fründt, Sören Weidemann, Christoph Schramm, Nicola Gagliani, Samuel Huber, Tanja Bedke. A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1307297
167
Andrew J. Muir. What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?. Clinical Gastroenterology and Hepatology 2020; 18(10) doi: 10.1016/j.cgh.2020.03.053
168
Rosario Fornaro, Michela Caratto, Elisa Caratto, Giuseppe Caristo, Francesco Fornaro, Davide Giovinazzo, Camilla Sticchi, Marco Casaccia, Enzo Andorno. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program. Clinical Colorectal Cancer 2016; 15(3) doi: 10.1016/j.clcc.2016.02.002
169
Fen Ming Zhang, Cheng Fu Xu, Guo Dong Shan, Hong Tan Chen, Guo Qiang Xu. Is gallstone disease associated with inflammatory bowel diseases? A meta‐analysis. Journal of Digestive Diseases 2015; 16(11) doi: 10.1111/1751-2980.12286
170
Haim Leibovitzh, Shadi Nayeri, Krzysztof Borowski, Cristian Hernandez-Rocha, Sun-Ho Lee, Williams Turpin, Joanne M Stempak, Iqbaljit Sandhu, Raquel Milgrom, Michelle I Smith, Kenneth Croitoru, Gideon M Hirschfield, Aliya Gulamhusein, Mark S Silverberg. Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile. Journal of Crohn's and Colitis 2024; 18(12) doi: 10.1093/ecco-jcc/jjae096
171
Jessica Colin Escobar, Maria Navarez Pereyra, Mohammad Ali Abbass. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Surgical Clinics of North America 2025; 105(2) doi: 10.1016/j.suc.2024.11.001
172
Serena Bertoni, Ariella Machness, Mattia Tiboni, Raquel Bártolo, Hélder A. Santos. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting. Biopolymers 2020; 111(1) doi: 10.1002/bip.23336
173
Craig Lammert, Veronica M. Loy, Kiyoko Oshima, Samer Gawrieh. Management of Difficult Cases of Autoimmune Hepatitis. Current Gastroenterology Reports 2016; 18(2) doi: 10.1007/s11894-015-0484-7
174
Nahla Azzam, Yazed AlRuthia, Othman Alharbi, Abdulrahman Aljebreen, Majid Almadi, Edward V. Loftus. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease. Hepatology International 2020; 14(6) doi: 10.1007/s12072-020-10110-5
175
Wassel Sannaa, Mazen Almasry, Mustafa Peedikayil, Alyssa A. Grimshaw, Mashary Attamimi, Abdulelah AlMutairdi, Badr Al-Bawardy. Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848241312766
176
Ming-Hsi Wang, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly Monroe, Billy D Nix, Rodney D Newberry, William A Faubion. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease. BMJ Open Gastroenterology 2023; 10(1) doi: 10.1136/bmjgast-2023-001141
177
Chengu Niu, Jing Zhang, Prajjwol Bhatta, Kaiwen Zhu, Nagesh Jadhav, Patrick I. Okolo, Asim Mushtaq, Ebubekir Daglilar. Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk. Journal of Internal Medicine 2025; 298(6) doi: 10.1111/joim.70026
178
Lukáš Bajer, Pavel Wohl, Pavel Drastich. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis. Vnitřní lékařství 2018; 64(6) doi: 10.36290/vnl.2018.090
179
James Luke Galloway, Abraham J. Matar, Vignesh Jayaraman Muralidharan, Randolph Steinhagen, Lauren Weaver, Wolfgang B. Gaertner, Kurt S. Schultz, Ira L. Leeds, Brendan P. Lovasik, William C. Chapman, Kinga S. Olortegui, Virginia O. Shaffer, Carla F. Justiniano, Michelle LaBella, Muneera R. Kapadia, Steven C. Kim, Jahnavi K. Srinivasan. Colorectal dysplasia and malignancy outcomes in primary sclerosing cholangitis and inflammatory bowel disease requiring liver transplantation and colectomy: A multicenter study. Surgery 2026; 195 doi: 10.1016/j.surg.2026.110230
180
Christopher L. Bowlus. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_25
181
João Sabino, Joren tenHove, Joana Torres. Biomarkers in Inflammatory Bowel Diseases. 2019;  doi: 10.1007/978-3-030-11446-6_16
182
Gordon W Moran, Morris Gordon, Vassiliki Sinopoulou, Shellie J Radford, Ana-Maria Darie, Sudheer Kumar Vuyyuru, Laith Alrubaiy, Naila Arebi, Jonathan Blackwell, Thomas D Butler, Thean Chew, Michael Colwill, Rachel Cooney, Gabriele De Marco, Said Din, Shahida Din, Roger Feakins, Marco Gasparetto, Hannah Gordon, Richard Hansen, Klaartje B Kok, Aditi Kumar, Christopher A Lamb, Jimmy Limdi, Eleanor Liu, Maurice B Loughrey, Dennis McGonagle, Kamal Patel, Polychronis Pavlidis, Christian Selinger, Matthew Shale, Philip J Smith, Sreedhar Subramanian, Stuart A Taylor, Gloria Shwe Zin Tun, Ajay Mark Verma, Newton A C S Wong. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut 2025; 74(Suppl 2) doi: 10.1136/gutjnl-2024-334395
183
Lina Lindström, Kristin K. Jørgensen, Kirsten M. Boberg, Maria Castedal, Allan Rasmussen, Andreas Arendtsen Rostved, Helena Isoniemi, Matteo Bottai, Annika Bergquist. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study. Scandinavian Journal of Gastroenterology 2018; 53(3) doi: 10.1080/00365521.2017.1421705
184
Patrick F. van Rheenen, Kaija‐Leena Kolho, Richard K. Russell, Marina Aloi, Annamaria Deganello, Séamus Hussey, Norman Junge, Jan De Laffolie, Mark R. Deneau, Emer Fitzpatrick, Anne M. Griffiths, Iva Hojsak, Emanuele Nicastro, Andreia Nita, Mikko Pakarinen, Amanda Ricciuto, Lissy de Ridder, Aurelio Sonzogni, Andrea Tenca, Marianne Samyn, Giuseppe Indolfi. Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group. Journal of Pediatric Gastroenterology and Nutrition 2025; 80(2) doi: 10.1002/jpn3.12378
185
Dibya L. Praharaj, Anil C. Anand. Hepatology. 2025;  doi: 10.1016/B978-0-443-26711-6.00036-6
186
Ondrej Fabian, Lukas Bajer, Peter Macinga, Jan Brezina, Mojmir Hlavaty, Pavel Drastich, Pavel Wohl, Karel Harant, Pavel Talacko, Eva Sticova, Andrea Vajsova, Alena Bohdanecka, Filip Tichanek, Monika Cahova, Alessandro Granito. Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol. PLOS One 2026; 21(1) doi: 10.1371/journal.pone.0341885
187
Jessica K Dyson, Ulrich Beuers, David E J Jones, Ansgar W Lohse, Mark Hudson. Primary sclerosing cholangitis. The Lancet 2018; 391(10139) doi: 10.1016/S0140-6736(18)30300-3
188
Atsushi Tanaka, Joachim C. Mertens. Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?. Inflammatory Intestinal Diseases 2016; 1(1) doi: 10.1159/000445259
189
G. V. Volynets. Primary sclerosing cholangitis and inflammatory bowel disease in children: a modern view of the problem. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2026; 71(1) doi: 10.21508/1027-4065-2026-71-1-125-133
190
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 2017; 67(6) doi: 10.1016/j.jhep.2017.07.022
191
Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2020;  doi: 10.1016/B978-0-12-814811-2.00004-9
192
Noa Krugliak Cleveland, David T. Rubin, John Hart, Christopher R. Weber, Katherine Meckel, Anthony L. Tran, Arthur S. Aelvoet, Isabella Pan, Alex Gonsalves, John Nick Gaetano, Kelli M. Williams, Kristen Wroblewski, Bana Jabri, Joel Pekow. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon. Clinical Gastroenterology and Hepatology 2018; 16(1) doi: 10.1016/j.cgh.2017.07.023
193
Igor G. Bakulin, Svetlana A. Burlakova, Ekaterina V. Skazyvaeva, Maria I. Skalinskaya. Registry of patients with autoimmune liver diseases in St. Petersburg: clinical and epidemiological data. HERALD of North-Western State Medical University named after I.I. Mechnikov 2024; 16(2) doi: 10.17816/mechnikov627505
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.